[HTML][HTML] Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang, J Huang, J Zhang… - BMC …, 2023 - Springer
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang, J Huang… - BMC …, 2023 - europepmc.org
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang, J Huang, J Zhang… - 2023 - pubmed.ncbi.nlm.nih.gov
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial.

W Luo, M Sun, J Wan, Z Zhang, J Huang… - BMC …, 2023 - search.ebscohost.com
Background: Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

[HTML][HTML] Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang… - BMC …, 2023 - bmcanesthesiol.biomedcentral.com
Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist that has a
rapid recovery from procedural sedation and can be fully reversed by flumazenil. To date …

Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang, J Huang… - BMC …, 2023 - search.proquest.com
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

[HTML][HTML] Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang, J Huang… - BMC …, 2023 - ncbi.nlm.nih.gov
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

[PDF][PDF] Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

W Luo, M Sun, J Wan, Z Zhang, J Huang, J Zhang… - bmcanesthesiol.biomedcentral.com
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …

Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial.

W Luo, M Sun, J Wan, Z Zhang, J Huang… - BMC …, 2023 - europepmc.org
Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist
that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil …